(2004). Clinical trials network. Re- trieved March 10, 2004, from the NIDA Web site: www.nida.nih.gov/ ctnPM, Johnson JA: Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network - LJ, HK, et al....
CTN BulletinClinical Trials April 9, 2008Network Volume 08 – 07CTN 0030 POATS Next Steering Committee MeetingThe Prescription Opiate Addiction Treatment The NIDA CTN Steering Committee Meeting will beStudy (POATS) sites continue to work hard held June 4-5, 2008 at the Hyatt Regency,recruiting pa...
The aim of the present study is to evaluate the efficacy and tolerability of risperidone in controlling aggressive behaviour in adults with mental retardation. Eighteen patients have been assessed for aggressivity through the Handicap Behaviour and Skill schedule (HBSs), for psychopathological aspects th...
privateEthereumnetwork, which can improve the scientific credibility of data findings inclinical trials. Apart from the traditionalblockchain, four new components have been developed to improve the quality and precision of medicine in clinical trials. They are the data management component for data ...
This presentation, by Betty Tai, Director of the Center for the Clinical Trials Network at NIDA, begins with a brief description of the CTN history, its overall goals, and its rectified vision to bring drug abuse treatment into mainstream medical practice. It then describes the CTN research por...
CTN: Canadian HIV Trials Network DSMB: Data and Safety Monitoring Boards EDCTP: European and Developing Countries Clinical Trials Partnership GCP: Good Clinical Practice GMP: Gates Malaria Partnership HIV: Human Immunodeficiency Virus ICH: International Conference of Harmonisation ICTRP: Internatio...
Clinical trials targeting transmembrane transport Overexpression of ABCB1 (also known as p-gp/MDR1) mediates increased drug efflux. Increased drug efflux makes attaining a sufficient intracellular concentration of drugs challenging, thus resulting in drug resistance [201,202]. The ABCB1 inhibitors (vera...
The National Drug Abuse Treatment Clinical Trials Network (CTN) has faced many challenges over its first eleven years. This review explores some of these c... B Tai,Sparenborg,Liu,... - 《Substance Abuse & Rehabilitation》 被引量: 17发表: 2011年 Selection and utilization of assessment instru...
The NIDA Center for Clinical Trials Network (CTN) sponsored two clinical trials assessing buprenorphine-naloxone for short-term opioid detoxification. These trials provided an unprecedented field test of its use in twelve diverse community-based treatment programs. Opioid-dependent men and women were ...
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Subcommittee on Cell and Gene Therapy convened a meeting of the investigators in the United States performing phase I clinical trials using CARs targeting CD19 on B-lineage malignancies, as well as representatives from the National ...